The largest database of trusted experimental protocols

Catch and release v2.0 reversible immunoprecipitation system

Manufactured by Merck Group
Sourced in United States, United Kingdom

Catch and Release v2.0 Reversible Immunoprecipitation System is a laboratory equipment designed for the isolation and purification of target proteins from complex biological samples. The system utilizes a reversible binding process to capture and release the proteins of interest, enabling efficient protein separation and analysis.

Automatically generated - may contain errors

22 protocols using catch and release v2.0 reversible immunoprecipitation system

1

Co-immunoprecipitation of TDP-43 and FMRP

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells/forebrain tissue were lysed in RIPA lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS) containing a protease inhibitor cocktail tablet (Roche). Extracts were quantified with the Bradford protein assay (Bio-rad). Protein extracts (0.5 mg-1 mg) were diluted to 0.5 mg/ml with lysis buffer.
Co-immunoprecipitation was performed using the Catch and Release v2.0 Reversible Immunoprecipitation System (Millipore) according to the manufacturer's instructions with either 4 μg anti-TDP-43 (Proteintech, Cat# 10782-2 AP) or 4 μg of anti-FMRP (Cell Signaling Technology, Cat# 4317). For western blot analysis, precipitated proteins were washed and subsequently eluted in denaturation buffer and heated at 94 °C for 3 min. For RNA-immunoprecipitation analysis, precipitated proteins were washed and subsequently eluted in non-denaturation buffer, and RNAs in the immunoprecipitates were purified using Quick-RNA™ Microprep Kit (ZYMO RESEARCH) according to the manufacturer's instructions.
+ Open protocol
+ Expand
2

Immunoprecipitation and Immunoblotting Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in lysis buffer (25 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 5% glycerol, 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM Na3VO4, 1 mM NaF, and 1 µg/ml aprotinin). Cell lysates containing an equal amount of protein (1.2 mg) were incubated with 4 μg anti-AR or anti-FAK antibody at 4 °C overnight. Protein–protein interactions were studied by performing immunoprecipitation using a Catch and Release v2.0 reversible immunoprecipitation system (Millipore Corporation), as per the manufacturer’s instructions. Thereafter, proteins in samples were resolved by sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE), transferred to PVDF membranes, and immunoblotted with anti-AR (Millipore PG-21 #06-680), anti-ARA55 (BD Biosciences #611164) or anti-FAK antibody (BD Biosciences #610088).
+ Open protocol
+ Expand
3

Investigating ANXA10-Cul4A Interaction

Check if the same lab product or an alternative is used in the 5 most similar protocols
Then, 293T cells were transiently co-transfected with pBabe-Cul4A-myc-his and pCMV6-ANXA10-GFP (OriGene, Rockville, MD, USA) vectors using Lipofectamine 2000 transfection reagent (Invitrogen). Twenty-four hours after transfection, the cells were treated with 10 μg/mL of MG132 (Sigma) for 24 h, and then harvested in a NP-40 lysis buffer (150 mM NaCl, 50 mM Tris [pH 8.0], 1% NP40), protease inhibitor, and phosphatase inhibitor cocktail (Roche, Lewes, UK, USA). Immunoprecipitation was performed using the Catch and Release v2.0 Reversible Immunoprecipitation System (Millipore) according to the manufacturer’s protocols. Anti-GFP (OriGene) and Anti-Cul4A (Abcam) antibodies were used for immunoprecipitation.
+ Open protocol
+ Expand
4

Foxf2 and Smad6 Interaction in hESCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
HESCs were harvested after stimulation of TGF‐β1 for 72 hours. Catch and Release® v2.0 Reversible Immunoprecipitation System (Millipore, USA) was used for Co‐IP test. The procedure followed the manufacturer's instruction. The cells were lysed, and then, 2 μg/mL of antibodies (Foxf2 or Smad6) was used to precipitate proteins. Anti‐rabbit immunoglobulin G monoclonal antibody (1:1000, Sigma‐Aldrich) was used as negative control in the experiments. The precipitated proteins were resolved to SDS‐PAGE and transferred to a PVDF membrane. The membranes were incubated with primary antibodies against Foxf2 or Smad6 (Abcam) overnight at 4°C, followed with secondary anti‐rabbit horseradish peroxidase‐conjugated IgG (1:1000, CST, USA), developed in ChemiDoc™ XRS+Imaging System using the chemiluminescence method (ECL, Millipore).
+ Open protocol
+ Expand
5

Co-IP of XBP1s and p300 in Hypoxic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
RAW264.7 cells were randomly assigned into normal control, hypoxia, hypoxia +0.1% DMSO (vehicle) and hypoxia +L002 (p300 inhibitor; 5 μmol/L for 24 hours) groups. The Catch and Release® v2.0 reversible immunoprecipitation system (#17‐500, Millipore, USA) was used for co‐IP. The cells were lysed, after which 2 μg/mL anti‐XBP1s (#40435) or anti‐p300 (#86377) antibodies purchased from Cell Signalling Technology were used to precipitate the proteins. Mouse anti‐rabbit IgG (#3678, Cell Signalling Technology; 1:1000) antibody was used as a negative control. The precipitated proteins were resolved by SDS‐PAGE and transferred to PVDF membranes. The membranes were incubated with primary antibodies against Ac‐K, XBP1s, p300 and GAPDH overnight at 4℃, followed by incubation with HRP‐conjugated goat‐anti‐rabbit IgG (31460, Invitrogen, USA; 1:1000), and the signals werer developed using the ECL method.
+ Open protocol
+ Expand
6

PGC1α-HSF1 Interaction in Apoptosis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lysates from differentiated WT and PGC1α-null cells were incubated with anti-HSF1 antibody (Abgent, San Diego, CA, USA, AJ1374a) and rabbit IgG (Santa Cruz, Dallas, TX, USA, sc-2027) and performed on Catch and Release v2.0 reversible immunoprecipitation system following the manufacturer's instructions (Millipore, Billerica, MA, USA). The immune complexes were eluted and subjected to SDS-PAGE. For immunoblot detection, we used anti-PGC1α (Santa Cruz, sc-13067) and anti-HSF1 (Abgent AJ1374a antibodies). The secondary goat anti-rabbit antibody was purchased from Santa Cruz (sc-2030). For western blot, proteins were extracted from cells using RIPA buffer, consisting of 20 mM Tris, 150 mM NaCl, 1% Triton X-100 and protease inhibitors (Roche) and separated in 4–20% or 10% Bis-Tris Gel (ThermoFisher, Rockville, MD, USA), transferred onto a PVDF membrane (Pierce, ThermoFisher) and incubated with primary antibodies including anti-Cleaved Caspase-3 (Cell Signaling, 9661, Danvers, MA, USA) and anti-β-actin (Sigma, A5316), overnight at 4 °C. Novex Sharp Pre-stained Protein Standard (ThermoFisher) was used as protein molecular size marker.
+ Open protocol
+ Expand
7

Immunoprecipitation of Robo1 from mmy embryos

Check if the same lab product or an alternative is used in the 5 most similar protocols
Because Robo1 was about threefold less abundant in mmyslm embryos than in wild-type embryos, we used 500 mmyslm embryos and 200 wildtype embryos for each immunoprecipitation experiment. Embryos that were aged for 12 to 14 hpf were homogenized in 37.5 μl of ice-cold lysis buffer [50 mM Hepes (pH 7.2), 100 mM NaCl, 1 mM MgCl2, 1 mM CaCl2, and 1% NP-40]. The lysates were incubated on ice for 30 min and centrifuged at 15,000g for 30min at 4°C. Thirty microliters of the supernatant was used as starting material for each IP reaction using the Catch and Release v2.0 Reversible Immunoprecipitation System (#17500; Millipore) using the manufacturer’s instructions. The columns were washed three times with 1× wash buffer (Millipore) at 2000g for 20 s, and the IP was done by adding the following to the columns in the following order: 435 μl of 1×wash buffer, 30 μl of cell lysate, 25 μl of the antibody recognizing Slit-C, and 10 μl of antibody capture affinity ligand. The columns were then incubated overnight at 4°C. The flow-through was collected, and the columns were washed three times with 1× wash buffer (2000g, 20 s) before elution in 60 μl of phosphate-buffered saline–based denaturing elution buffer (2000g, 20 s). The proteins were then resolved on 4 to 12% SDS-PAGE and immunoblotted and probed with an antibody recognizing Robo1 (1:40, mouse, 13C9; DHSB).
+ Open protocol
+ Expand
8

Immunoprecipitation-Western Blot Assay for TTR Autoantibodies in RA

Check if the same lab product or an alternative is used in the 5 most similar protocols
To ascertain the significance of increase level of TTR in the diagnosis of RA, autoantibodies in the plasma of RA patients and healthy individuals were detected using immunoprecipitation-Western blotting methods. Immunoprecipitation (IP) was performed using Catch and Release v2.0 reversible immuno-precipitation system (Millipore, USA) as per manufacturer's instructions. Briefly, plasma proteins (500 μg) of individual RA patients was incubated for 2 h in mild shaking condition at RT with anti-TTR antibody separately along with 10 μl antibody capture affinity ligand buffer. The antigen-antibody complexes were eluted with 70 μl elution buffer and separated on 12% SDS–PAGE. Proteins were transferred to nitrocellulose membrane (Millipore, USA) and blocking was carried out using 5% bovine serum albumin (BSA) for 1 h at RT with gentle shaking. Plasma of RA and healthy individuals was added to the membrane as a primary antibody for overnight incubation at 4°C. After each step, the membrane was washed with PBST. The membrane was then incubated with HRP conjugated anti-human antibody for 1 h at RT with mild shaking. Enhanced chemiluminescence assay (ECL) (Thermo-Scientific, Pierce, USA) was used to develop the membrane and autoradiographed on high performance chemiluminescence film (GE Healthcare).
+ Open protocol
+ Expand
9

Quantifying Cathepsins and Cystatin C in AAA

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the levels of cathepsins B, D, K, L and S and cystatin C in the serum of AAA patients and the 10 healthy volunteers, immunoprecipitation was performed using the Catch and Release v2.0 Reversible Immunoprecipitation System, according to the manufacturer's instructions (Millipore Corporation, Billerica, MA, USA). The following Abs were used for detection: cathepsin B (ab30443, Abcam), cathepsin D (ab6313, Abcam), cathepsin K (ab37259, Abcam), cathepsin L (ab49984, Abcam), cathepsin S (ab18822, Abcam) and cystatin C (rabbit polyclonal to cystatin C; ab33487, Abcam). Following immunoprecipitation, the samples underwent western blot analysis as described above.
+ Open protocol
+ Expand
10

Kinase Activity Assay for CK1α and GRK2

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were lysed in co-IP buffer, and non-denatured CK1α and GRK2 proteins for kinase assay were obtained using Catch and Release® v2.0 Reversible Immunoprecipitation System (Millipore, Burlington, MA, USA) according to the manufacturer’s instructions. In brief, 500 μg of indicated cell lysates were incubated with anti-CK1α antibody (#sc-74582, Santa Cruz Biotechnology, Inc) or anti-GRK2 antibody (#sc-13143, Santa Cruz Biotechnology, Inc) and 10 μl of antibody capture affinity ligand in a Catch and Release v2.0 spin column. After 12 h end-over-end shaking, the column was centrifuged, washed, and then eluted with non-denaturing elution buffer. The IP-CK1α and IP-GRK2 eluates were subjected to further kinase assay using CK1α1 Kinase Enzyme System and GRK5 Kinase Enzyme System (Promega, Madison, WI, USA) respectively according to the manufacturer’s instructions. Briefly, indicated eluates were incubated with ATP/substrate Mix for 60 min at room temperature, followed by ADP detection with ADP-Glo™ Kinase Assay (Promega Madison, WI, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!